scispace - formally typeset
N

Nobuyuki Takahashi

Researcher at Kyoto University

Publications -  260
Citations -  8813

Nobuyuki Takahashi is an academic researcher from Kyoto University. The author has contributed to research in topics: Peroxisome proliferator-activated receptor & Adipose tissue. The author has an hindex of 47, co-authored 223 publications receiving 7831 citations. Previous affiliations of Nobuyuki Takahashi include Kanagawa University & Graduate University for Advanced Studies.

Papers
More filters
Journal ArticleDOI

Ezrin/Radixin/Moesin (ERM) Proteins Bind to a Positively Charged Amino Acid Cluster in the Juxta-Membrane Cytoplasmic Domain of CD44, CD43, and ICAM-2

TL;DR: It is concluded that ERM proteins bind to integral membrane proteins bearing a positively charged amino acid cluster in their juxta-membrane cytoplasmic domain.
Journal ArticleDOI

PPARγ coactivator 1β/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity

TL;DR: It is demonstrated that PGC-1β/ERRL1 can function as a protein ligand of ERR, and that its level contributes to the control of energy balance in vivo, and provide a strategy for developing novel antiobesity drugs.
Journal ArticleDOI

Oxytocin receptor-deficient mice developed late-onset obesity.

TL;DR: It is demonstrated that oxytocin receptor plays essential roles in the regulation of energy homeostasis with late-onset obesity with increases in abdominal fat pads and fasting plasma triglycerides in Oxtr−/− mice.
Journal ArticleDOI

Dual action of isoprenols from herbal medicines on both PPARγ and PPARα in 3T3-L1 adipocytes and HepG2 hepatocytes

TL;DR: The results suggest that herbal medicines containing isoprenols with dual action on both PPARγ and PPARα can be of interest for the amelioration of lipid metabolic disorders associated with diabetes.
Journal ArticleDOI

Volume-sensitive chloride channels involved in apoptotic volume decrease and cell death.

TL;DR: Blocking the VSOR Cl− channel prevented cell death in not only epithelial and cardiac cells, but also other cell types, by inhibiting the induction of AVD and subsequent apoptotic events.